MKEA.PA

Mauna Kea Technologies SA [MKEA.PA] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

MKEA.PA Stock Summary

In the News

MKEA.PA Financial details

Company Rating
-
Market Cap
30.17M
Income
0
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
68
Optionable
No
Shortable
Yes
Earnings
28 Sep 2023
P/E
-2.48
Forward P/E
-
PEG
-
P/S
4.03
P/B
-1.39
P/C
-
P/FCF
-3.36
Quick Ratio
0.94
Current Ratio
1.19
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0
EPS next Y
-
EPS next Q
-
EPS this Y
-34.38%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-14.88%
Revenue last 5Y
2.04%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-56%
ROE
74%
ROC
-1.26%
Gross Margin
73%
Oper. Margin
-120%
Profit Margin
-149%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.402-0.92
52W High
-
52W Low
-
RSI
-
Rel Volume
0.06
Avg Volume
158.86K
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
1.44436
-
-
Volatility
0.01%, 0.01%
Prev Close
-
Price
-
Change
-

Something similar

Top by Market Cap
M&M.NS
APC.DE
AAPL
1YD.DE
VTSAX
Same Sector
LUPIN.NS
BTL.DE
ALVAL.PA
INMB
BCRX
Check Those
OMU.L
UMI.TO
BBSE3.SA
600178.SS
600572.SS
Similar Market Cap
ATER
UXI
CNBA
SPBC
MDA.PA

Company Profile

Healthcare Medical - Devices
  • Volume Average 158.86K
  • Market Capitalization 30.17M
  • Employee 68
  • CEO Mr. Alexandre Loiseau Ph.D.
  • Headquarters Paris,FR
  • IPO Date 2011-07-06
  • Website https://www.maunakeatech.com

Mauna Kea Technologies SA develops and markets medical devices in Europe, the Middle East, Africa, the United States, Latin America, and Asia. The company designs, develops, and markets tools to visualize and detect cell abnormalities in real time during standard gastrointestinal and pulmonary endoscopy procedures. Its flagship product is Cellvizio, a confocal miniprobe endomicroscopy system which provides physicians and researchers high-resolution images of tissues at the cellular level. The company was incorporated in 2000 and is headquartered in Paris, France.